| Financial Year |
September 30 2022 |
| Monetary Funds |
182,770,027.71 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
222,688,695.79 |
| Advances to Suppliers |
36,921,995.32 |
| Other Receivables |
54,365,423.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
4,102,438.06 |
| Dividend Receivable |
-- |
| Inventories |
68,383,956.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,679,610.76 |
| Total Current Assets |
577,809,710.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
606,400.00 |
| Long-term Equity Investment |
-- |
| Investment Properties |
35,733,970.07 |
| Fixed Assetes |
13,202,277.70 |
| Under-construction Projects |
115,971,869.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,840,881.39 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,803,451.82 |
| Deferred Income Tax Assets |
4,269,757.92 |
| Other Non-Current Assets |
5,000,000.00 |
| Sub-Total of Non-Current Assets |
2,178,579,013.81 |
| Total Assets |
2,756,388,723.89 |
| Short-Term Loans |
27,953,037.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
43,968,063.12 |
| Accounts Received In Advance |
167,870.47 |
| Employee Compensation Payable |
5,545,800.92 |
| Taxes Payable |
32,713,177.69 |
| Interest Payable |
155,208.41 |
| Dividend Payable |
206,029.02 |
| Other payables |
179,533,902.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,475,040.82 |
| Other Current Liabilities |
20,824,662.77 |
| Sub-Total of Current Liabilities |
322,251,428.08 |
| Long-term Loans |
4,600,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
37,105,317.55 |
| Deferred Income Tax Liabilities |
535,579.31 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
76,107,513.15 |
| Total Liabilities |
398,358,941.23 |
| Paid-In Capital(Or Share Stock) |
522,777,419.00 |
| Capital Surplus |
4,349,214,744.06 |
| Surplus Reserve |
63,193,565.61 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,562,701,791.25 |
| Minority Stockholder's Interest |
-15,441,993.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,373,471,776.42 |
| Owner's Equity（Stockholder's Equity） |
2,358,029,782.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,756,388,723.89 |
